Behçet’s disease and malignization: Literature review and authors’ data


Cite item

Full Text

Abstract

The paper describes cancers (enteric adenocarcinoma in one case and acute leukemia in the other) in 2 patients with Behçet’s disease (BD) followed up at the V.A. Nasonova Research Institute of Rheumatology. It gives the data available in the literature on BD concurrent with malignant tumors. This concurrence is noted to substantially worsen the prognosis of the disease as a whole.

References

  1. Алекберова З.С. Болезнь Бехчета. Научно-практическая ревматология. 2013;1:52-57.
  2. Yazici H, Esen F. Mortality in Behcet’s syndrome. Clin ExpRheum. 2008;26(suppl. 51):138-140.
  3. Saadoun D, Wechsler B, Desseaux K, Le Thi Huong D, Amoura Z, Resche-Rigon M, Cacoub P. Mortality in Behcets disease. Arthritis Rheum. 2010;62(9):2806-2812.
  4. Kaklamani VG, Tzonou A, Kaklamanis PG. Behçet’s disease associated with malignancies. Report of two cases and review of the literature. Clin Exp Rheumatol. 2005;23(Suppl. 38):S35-S41.
  5. Na SY. Morbidity of solid cancer in Behсet’s disease: analysis of 11 cases in a series of 506 patients. Yonsei Med J. 2013;54(4):895-901.
  6. International Study Group for Behcet’s Disease: Criteria for diagnosis of Behcet’s disease. Lancet. 1990;335:1078-1080.
  7. Rutter M, Saunders B, Wilkinson K, Rumbles S, Scjfield G, Kamm M, Williams C, Price A, Talbot I, Forbes A. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451-459.
  8. Jess TI, Loftus EV Jr, Velayos FS, Harmsen WS, Zinsmeister AR, Smyrk TC, Schleck CD, Tremaine WJ, Melton LJ 3rd, Munkholm P, Sandborn WJ. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology. 2006;130:1039-1046.
  9. Cengiz MI, Altundag MK, Zorlu AF, Güllü IH, Ozyar E, Atahan IL. Malignancy in Behсet’s disease: a report of 13 cases and a review of the literature. Clin Rheumatol. 2001;20:239-244.
  10. Yamada M. Colon cancer arising in an ulcer scar due to intestinal Behсet’s disease. Intern Med 2011;50:429-432.
  11. Barhoumi A, Hamzaoni A, Hammami S, Manjoub S. «Behcet`s disease associated with malignancies. Report of three cases». Clin Exp Rheum. 2008;26:3 (suppl. 50):S1-21.
  12. Tassies D, Cervantes F, Feliu E, Cabal G, Martínez Orozco F, Rozman C. Behcet’s disease with an onset prior to the appearance of chronic myeloid leukemia. Med Clin. 1992;99:67-68.
  13. Segawa F, Shimizu Y, Saito E, Kinoshita M. Behcet’s disease induced by interferon therapy for chronic myelogenous leukemia. J Rheumatol. 1995;22:1183-1184.
  14. Budak-Alpdogan T, Demircay Z, Alpdogan O, Direskeneli H, Ergun T, Bayik M, Akoğlu T. Behcet’s disease in patients with chronic myelogenous leukemia: possible role of interferon-a treatment in the occurrence of Behcet’s symptoms. Ann Hematol. 1997;74:45-48.
  15. Vaiopoulos G, Terpos E, Viniou N, Nodaros K, Rombos J, Loukopoulos D. Behcet’s disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature. AmJ Hematol. 2001;66:57-58.
  16. Budak-Alpdogan T, Demircay Z, Alpdogan O. Skin hyperreactivity of Behcet’s patients (pathergy reaction) is also positive in interferon-a treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disorders. Br J Rheumatol. 1998;37:1148-1151.
  17. Vardiman JW, Melo JV, Baccarani M. Chronic myelogenous leukaemia, BCR-ABL1 positive. In: Swerdlow SH, Campo E, Harris NL et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. WHO Classification of Tumours; vol 2. 4th ed. Lyon, France: IARC Press; 2008:32-37.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies